About 10 to 15 million people around the world have type 1 diabetes and require insulin to make up for the pancreas’ inability to produce enough for the body’s use. In the September 28, 2006 issue of the New England Journal of Medicine researchers from the University of Alberta studied how the clinical outcomes of transplanting insulin producing cells or islet cells into people with type 1 diabetes affected them.

• Dr. James Shapiro, Director, Clinical Islet Transplant Program, University of Alberta CIHR Clinical Research Professorial Chair in Transplantation